Hera BioLabs

Hera BioLabs

Hera provides preclinical contract research services from gene editing, and cell line development, to drug efficacy, metabolism, and toxicology studies. Starting with the Cas-CLOVER and piggyBac gene editing technologies, Hera is building novel preclinical models for improved predictability and translation- including humanized liver, humanized immune system, bioproduction platforms, transgenic animal models, etc.

Acute Toxicology, Cancer Biology/Carcinogenicity, Molecular Biology/Synthesis, Pharmaceutical Toxicology, CRO—Contract Research Organization, Preclinical, Efficacy Testing, Transgenic Models